Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 4 (2007), Issue 6 (June)

1. Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.
   Am J Psychiatry, 164(6): 916-21. [Abstract] [Full-text]
2. Nursing home placement, day care use, and cognitive decline in Alzheimer's disease.
   Am J Psychiatry, 164(6): 910-5. [Abstract] [Full-text]
3. Imaging of acetylcholine esterase activity in brainstem nuclei involved in regulation of sleep and wakefulness.
   Eur J Neurol, 14(6): 690-3. [Abstract] [Full-text]
4. What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia?
   Eur J Neurol, 14(6): 679-82. [Abstract] [Full-text]
5. Polymorphisms at codons 129 and 219 of the prion protein gene (PRNP) are not associated with sporadic Alzheimer's disease in the Korean population.
   Eur J Neurol, 14(6): 621-6. [Abstract] [Full-text]
6. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
   Neurobiol Aging, 28(8): 1206-14. [Abstract] [Full-text]
7. Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease.
   Neurobiol Aging, 28(8): 1239-47. [Abstract] [Full-text]
8. Early discrimination reversal learning impairment and preserved spatial learning in a longitudinal study of Tg2576 APPsw mice.
   Neurobiol Aging, 28(8): 1248-57. [Abstract] [Full-text]
9. Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients.
   Neurobiol Aging, 28(8): 1163-9. [Abstract] [Full-text]
10. Short latency afferent inhibition is not impaired in mild cognitive impairment.
    Clin Neurophysiol, 118(7): 1460-3. [Abstract] [Full-text]
11. Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology.
    J Clin Invest, 117(6): 1595-604. [Abstract] [Full-text]
12. A beneficial role for IL-1 beta in Alzheimer disease?
    J Clin Invest, 117(6): 1483-5. [Abstract] [Full-text]
13. Autophagocytosis of mitochondria is prominent in Alzheimer disease.
    J Neuropathol Exp Neurol, 66(6): 525-32. [Abstract] [Full-text]
14. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.
    J Neuropathol Exp Neurol, 66(6): 469-80. [Abstract] [Full-text]
15. Application of automated medial temporal lobe atrophy scale to Alzheimer disease.
    Arch Neurol, 64(6): 849-54. [Abstract] [Full-text]
16. Activities of daily living in frontotemporal dementia and Alzheimer disease.
    Neurology, 68(24): 2077-84. [Abstract] [Full-text]
17. Neurophysiologic analyses of low- and high-level visual processing in Alzheimer disease.
    Neurology, 68(24): 2066-76. [Abstract] [Full-text]
18. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
    Expert Rev Neurother, 7(6): 735-48. [Abstract] [Full-text]
19. Long-term outcome of depressive pseudodementia in the elderly.
    J Affect Disord, 101(1): 123-9. [Abstract] [Full-text]
20. Systematic review of the effect of psychological interventions on family caregivers of people with dementia.
    J Affect Disord, 101(1): 75-89. [Abstract] [Full-text]
21. Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration.
    J Neurol Neurosurg Psychiatry, 78(7): 735-7. [Abstract] [Full-text]
22. Autonomic dysfunction in dementia.
    J Neurol Neurosurg Psychiatry, 78(7): 671-7. [Abstract] [Full-text]
23. Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro.
    Biochem Biophys Res Commun, 359(3): 697-702. [Abstract] [Full-text]
24. Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis.
    J Neurosci, 27(25): 6771-80. [Abstract] [Full-text]
25. Morphological substrate of face matching in healthy ageing and mild cognitive impairment: a combined MRI-fMRI study.
    Brain, 130: 1745-58. [Abstract] [Full-text]
26. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.
    Brain, 130: 1777-86. [Abstract] [Full-text]
27. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.
    Brain, 130: 1767-76. [Abstract] [Full-text]
28. Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease.
    BMC Neurol, 7: 14. [Abstract] [Full-text]
29. Phenserine.
    Expert Opin Investig Drugs, 16(7): 1087-97. [Abstract] [Full-text]
30. Alzheimer-like changes in rat models of spontaneous diabetes.
    Diabetes, 56(7): 1817-24. [Abstract] [Full-text]
31. Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin).
    J Neurosci, 27(26): 7006-10. [Abstract] [Full-text]
32. Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease.
    J Neurosci, 27(26): 6859-67. [Abstract] [Full-text]
33. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
    J Phys Chem B, 111(26): 7646-55. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.